Quantcast
Channel: Euroinvestor.com A/S
Browsing all 18 articles
Browse latest View live

MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK &...

NEW ORLEANS, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...

View Article



DEADLINE ALERT: Brower Piven Notifies Shareholders of Upcoming Deadline In...

STEVENSON, Md., Dec. 08, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United...

View Article

Momenta and Mylan Report Initial Results from Phase 1 Clinical Trial for...

CAMBRIDGE, Mass. and HERTFORDSHIRE, United Kingdom and PITTSBURGH, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) and Mylan N.V. (NASDAQ:MYL) (TASE:MYL), today announced...

View Article

New Research Coverage Highlights Mylan, Genworth Financial, Chevron, Southern...

NEW YORK, Nov. 02, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and...

View Article

Market Trends Toward New Normal in Patterson-UTI Energy, SAExploration, vTv...

NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and...

View Article


Momenta and Mylan Announce Development Strategy for M710, a Proposed...

CAMBRIDGE, Mass., HERTFORDSHIRE, United Kingdom and PITTSBURGH, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) and Mylan N.V. (NASDAQ:MYL) (TASE:MYL) today announced the...

View Article

Detailed Research: Economic Perspectives on OUTFRONT Media, Mylan N.V,...

NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and...

View Article

Factors of Influence in 2018, Key Indicators and Opportunity within Regency...

NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and...

View Article


Report: Developing Opportunities within Sunoco LP, Mylan N.V., Ares...

NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...

View Article


Mapi Pharma Presents Phase II Extension Results of Glatiramer Acetate Depot...

81.8% Patients on GA Depot Demonstrated No Evidence of Disease Activity (NEDA) at 2 yearsGA Depot Has Potential to Address Multiple Sclerosis Treatment Burden and Improve Patient ComplianceNESS ZIONA,...

View Article

Consolidated Research: 2018 Summary Expectations for Green Brick Partners,...

NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders,...

View Article

Market Trends Toward New Normal in Hasbro, Spark Energy, QUALCOMM, Green...

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...

View Article

Mapi Pharma to Host Key Opinion Leader Meeting on Long Acting Glatiramer...

NESS ZIONA, Israel, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical late stage biopharmaceutical company, announced today that it will host a Key Opinion Leader (KOL)...

View Article


New Research: Key Drivers of Growth for Toll Brothers, Mylan N.V, Eldorado...

NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders,...

View Article

Mapi Pharma Receives Government of Israel Funding for the Establishment of a...

NESS ZIONA, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical, late stage biopharmaceutical company, announced today that it has received complementary funding...

View Article


Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele...

MONTREAL, June 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), a leading specialty pharmaceutical company with a strong North American...

View Article

Mapi Pharma to Build a New Sterile Injectable Production Plant for GA Depot...

NESS ZIONA, Israel, July 15, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company announced today that is has signed a long term...

View Article


Mapi Pharma to Present Series of Recent Advancements for Treating Multiple...

Results for Glatiramer Acetate (GA) Depot 3 year analysis in RRMS, GA Depot safety results in RRMS and PPMS, and novel anti-BMP for remyelination will be presentedECTRIMS 2019 to be held in Helsinki,...

View Article
Browsing all 18 articles
Browse latest View live




Latest Images